TERT and cancer: Furthermore, in accordance with other studies analyzing TERT mutations in cancer patients [25,30,31,32,33,34], we found that MIBC patients harboring TERT c.1-124C>T had a worse clinical outcome than those without the mutation, emphasizing the aggressive role of the TERT mutation in MIBC.